Seafood/fish intake has been regarded as a protective factor for coronary heart disease (CHD), while smoking is a strong risk factor. To examine whether associations between smoking and risk of CHD are modified by seafood/ fish intake, we studied 72,012 Japanese men and women aged 45-74 years who completed 2 food frequency questionnaires, 5 years apart, during the period 1995-2009. After 878,163 person-years of follow-up, 584 incident cases of CHD (101 fatal and 483 nonfatal), including 516 myocardial infarctions, were documented. There was a clear dose-response association between smoking and CHD risk among subjects with a low seafood/fish intake (<86 g/day) but not among those with a high seafood/fish intake (≥86 g/day). Compared with never smokers, the multivariable hazard ratios in light (1-19 cigarettes/day), moderate (20-29 cigarettes/day), and heavy (≥30 cigarettes/day) smokers were 2.39 (95% confidence interval (CI): 1.60, 3.56), 2.74 (95% CI: 1.90, 3.95), and 3.24 (95% CI: 2.12, 4.95), respectively, among low seafood/fish eaters and 1.13 (95% CI: 0.64, 1.99), 1.29 (95% CI: 0.95, 2.04), and 2.00 (95% CI: 1.18, 3.51), respectively, among high seafood/fish eaters. Compared with heavy smokers with a low seafood/fish intake, light smokers with a high seafood/fish intake had substantially reduced risk of CHD (hazard ratio = 0.57, 95% CI: 0.32, 0.98). High seafood/fish intake attenuated the positive association between smoking and risk of CHD. coronary heart disease; fish intake; follow-up studies; seafood intake; smoking Abbreviations: CHD, coronary heart disease; CI, confidence interval; FFQ, food frequency questionnaire; JPHC, Japan Public Health Centre-based Prospective Study on Cancer and Cardiovascular Disease.
Fish intake, in both small (1, 2) and large (3) (4) (5) amounts, is inversely associated with risk of coronary heart disease (CHD). Regarding both the exposure variable (seafood/fish intake) and the outcome (CHD), Japan is unique; it has a very high seafood/fish intake (>3 times that of Western populations (6)) and a very low incidence of CHD (3-5 times lower than that of Western populations (7)).
Compared with Western countries, Japanese men had a high proportion of current smokers (47%) in 2000, while Japanese women had a low proportion (11%) (8) . However, the proportion of current smokers among Japanese women aged 20-49 years has increased since 1990 (8) . The epidemiologic evidence supporting a positive association between cigarette smoking and CHD is very strong (9) . Smoking is common in Japan, but the Japanese population has low rates of CHD, which suggests that high fish intake may account for the lower CHD rates observed relative to other populations (5, 10, 11) . A prospective study in middle-aged JapaneseAmerican men showed that high fish intake may limit the increase in risk of CHD morbidity and mortality among heavy smokers (≥30 cigarettes/day) (12) . However, a case-control study among Greeks showed that moderate fish consumption but not high fish consumption was inversely associated with CHD risk among smokers (13) . To our knowledge, no other published data about a joint association or interaction between seafood/fish intake and smoking status in the risk of CHD have been released. Using data from a nationwide study, the Japan Public Health Centre-based Prospective Study on Cancer and Cardiovascular Disease (JPHC Study), we examined whether the association between smoking and risk of CHD was modified by seafood/fish intake. We hypothesized that a high seafood/fish intake may limit the increase in risk of CHD, even among smokers.
METHODS

Study population
The JPHC Study, a large, nationwide Japanese prospective cohort study, was launched in 2 phases at a number of public health centers: 5 public health centers for cohort I (in 1990) and 6 public health centers for cohort II (in 1993). The study design has been described in detail previously (14) . Three questionnaire surveys were conducted: at baseline in 1990 (cohort I) and 1993 (cohort II) and at 5-and 10-year followups. Because the 5-year follow-up survey included a more comprehensive food frequency questionnaire (FFQ) than the baseline surveys, the 5-year survey was used as the baseline (starting point) for the present study. At the time of the 5-year survey, subjects were aged 45-64 years in cohort I and aged 45-74 years in cohort II. Information on medical histories and health-related lifestyle factors, such as smoking, alcohol drinking, and dietary habits, was obtained. This study was approved by the institutional review board of the National Cancer Centre of Japan.
We excluded subjects at 2 public health centers because of differences in recruitment criteria. After exclusion of 5,681 persons who had died, moved out of a study area, or were lost to follow-up before the starting point, the remaining 92,900 subjects were eligible for participation. Of these, 80,964 subjects responded (response rate = 87.2%) and were included in the present study. We excluded subjects who reported a history of myocardial infarction, cerebrovascular disease, or cancer (n = 3,398) before the starting point. Based on the 5-year FFQ assessment, an additional 5,203 subjects with missing information about seafood/fish intake and/or smoking habits and 351 subjects who reported extreme total energy intakes (outside the range of the mean ± 3 standard deviations) were excluded, which left a total of 72,012 subjects (32,982 men and 39,030 women) who were ultimately included in our analysis.
Dietary assessment
The FFQs administered during the 5-and 10-year surveys assessed the average intake of 147 food and beverage items, including 19 seafood/fish items (7 types of fresh fish (salmon, skipjack/tuna, cod/flatfish, sea bream, horse mackerel/sardine, saury/mackerel, and eel), 5 seafoods other than fish (squid, octopus, shrimp, clam, and pond snail), 4 salted and dried fish products (salted fish, dried fish, dried whitebait, and salted fish roe), and 3 other fish products (canned tuna and 2 fish-paste products, chikuwa and kamaboko)), over the previous year. For most food items, 9 response options were available to describe consumption frequency, ranging from rarely to 1-3 times/month; 1-2, 3-4, or 5-6 times/week; and 1, 2-3, 4-6, or ≥7 times/day. A standard portion size was specified for each food. The daily intakes of seafood/fish and all food items were calculated by multiplying daily consumption frequency by the typical portion size (14) .
For different seafood/fish intakes, the Spearman correlation coefficients for correlation between 2 administrations of the 5-year FFQ, 1 year apart, among 244 men and 254 women ranged from 0.50 to 0.73 in men and from 0.52 to 0.69 in women, and those for correlation between the 5-year FFQ and four 1-week dietary records ranged from 0.20 to 0.57 in men and from 0.25 to 0.49 in women. The mean intakes of seafood/fish were 102 g/day in men and 87 g/day in women according to the 5-year FFQ and were 99 g/day in men and 73 g/day in women according to the dietary records (14) . Web Figure 1 (available at http://aje. oxfordjournals.org/) shows the distribution of daily seafood/fish consumption in our subjects, represented by the mean value and interquartile range.
In the second and third survey questionnaires, the questions were about current smoking status, average number of cigarettes smoked per day for current smokers, and reasons for cessation of smoking for former smokers.
Endpoint assessment
CHD events were included in the study if they occurred between the return of the 5-year questionnaire and the end of 2009 in cohort I or the end of 2007 in cohort II. Seventy-eight major hospitals with the capacity to treat patients for CHD were registered within the administrative districts of the JPHC cohorts. Physicians, unaware of the patients' lifestyle data, reviewed the medical records at each hospital. Myocardial infarction was confirmed in the medical records according to the criteria of the MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Project (7), which requires evidence from electrocardiograms, cardiac enzymes, or autopsy. Subjects who moved away from their original residential areas (2% of the subjects), identified through the residential registry, were treated as censored at that time.
Statistical analysis
Statistical analyses were based on incidence rates of CHD during the follow-up period. For each individual, personmonths of follow-up were calculated from January 1, 1995 (in cohort I) or January 1, 1998 (in cohort II) onward, until one of 4 endpoints had been achieved: incidence of the first CHD event, death, emigration, or December 31, 2009 (in cohort I) or December 31, 2007 (in cohort II), whichever came first. We tested for effect modification by seafood/fish intake in the association between smoking status (never smokers; former smokers; and current light smokers (<20 cigarettes/ day), moderate smokers (20-29 cigarettes/day), or heavy smokers (≥30 cigarettes/day)) and risk of CHD. Hazard ratios and 95% confidence intervals were calculated after adjustment for age, sex, and other potentially confounding factors with time-dependent Cox proportional hazards models. We updated the information on dietary intake, smoking status, and the confounding factors listed below (except for age, sex, and public health center) from the 10-year follow-up survey, to which 88.7% of the subjects responded. Accordingly, dietary intakes and smoking status at the time of the 5-year survey were related to the incidence of CHD that occurred during the time period between the 5-and 10-year surveys, and dietary intakes and smoking status at the time of the 10-year survey were related to the incidence of CHD that occurred from the time of the 10-year survey to the end of the study. For subjects who had not responded to the 10-year survey and had incident CHD afterwards, smoking status and intakes reported on the 5-year survey were used. Potentially confounding factors included for statistical adjustment were age (5-year categories); sex; public health center; alcohol intake (nondrinkers; occasional drinkers; and weekly ethanol intake of <150 g/week, 150-<300 g/week, 300-<450 g/week, or ≥450 g/week); body mass index (weight (kg)/height (m) 2 ); histories of hypertension and diabetes (yes or no); medication use for hypercholesterolemia (yes or no); sports during leisure time (<1 day/month, 1-3 days/month, and ≥1 day/week); and quintiles of dietary intake of fruits, vegetables, saturated fat, monounsaturated fat, n-6 polyunsaturated fat, cholesterol, and total energy.
There was no evidence that proportional hazards assumptions were violated, as indicated by the lack of significant interaction between the predictors and a function of survival time in the model. Two different sex interaction terms were generated and tested by means of the Wald test; seafood/ fish consumption (continuous) × sex (0, 1) and smoking stratum (0, 1, 2) × sex (0, 1); neither term was significant (P > 0.05 for all CHD events). Another interaction term was generated for seafood/fish consumption (continuous) × smoking stratum (0, 1, 2); the P value for interaction was less than 0.05 for all CHD events, except fatal coronary events. The analyses were conducted with SAS, version 9.3 (SAS Institute, Inc., Cary, North Carolina). All P values presented are 2-sided, and P < 0.05 was regarded as statistical significance. Table 1 shows updated information on cardiovascular disease risk factors and intakes of selected nutrients and foods according to smoking status, stratified by dietary intake of seafood/fish. The prevalence of current smoking was 41% for men, 4% for women, and 21% for all subjects. In both low and high seafood/fish eaters, compared with never smokers, former smokers were more likely to be hypertensive and diabetic and to consume more alcohol. Compared with never smokers, subjects across increasing strata of current smoking (light, moderate, and heavy) were on average 4-5 years younger and less likely to practice sports, to be hypertensive, and to use lipid-lowering drugs but were more likely to be diabetic and to consume more alcohol and total energy. Increasing number of cigarettes smoked per day was associated with less consumption of fatty acids, cholesterol, fruits, and vegetables. Seafood/fish intake decreased across the smoking strata in subjects with low seafood/fish intake, whereas it increased across the smoking strata in those with high seafood/ fish intake.
RESULTS
During 878,163 person-years of follow-up, we documented 584 incident cases of CHD (428 men and 156 women). There were 101 (74 men and 27 women) fatal coronary events and 483 (354 men and 129 women) nonfatal coronary events, including 516 (376 men and 140 women) myocardial infarctions.
The multivariable-adjusted hazard ratio for total CHD risk in the highest quintiles of seafood/fish intake versus the lowest quintiles were 0.83 (95% confidence interval (CI): 0.61, 1.17; P-trend = 0.25) for all subjects, 1.28 (95% CI: 0.78, 1.79; P-trend = 0.42) for never smokers, 0.90 (95% CI: 0.69, 2.06; P-trend = 0.67) for former smokers, and 0.63 (95% CI: 0.39, 1.02; P-trend = 0.05) for current smokers. Among current smokers, the reduced risk of CHD observed in the highest quintiles of seafood/fish intake compared with the lowest quintiles was primarily observed for nonfatal coronary events (hazard ratio = 0.55, 95% CI: 0.36, 0.92), not for fatal coronary events (hazard ratio = 1.62, 95% CI: 0.59, 2.51) (not shown in tables). Table 2 shows the multivariable hazard ratio for CHD risk according to smoking stratum in all subjects and in subjects with low and high seafood/fish intakes. A positive doseresponse association between cigarette smoking and risk of CHD was evident in all subjects and in subjects with a low seafood/fish intake (less than the median of 86 g/day). On the other hand, among subjects with a high seafood/fish intake (median or more; ≥86 g/day), the association between smoking and risk of CHD was attenuated and modified in light and moderate smokers; hazard ratios were 1.13 (95% CI: 0.64, 1.99), 1.29 (95% CI: 0.95, 2.04), and 2.00 (95% CI: 1.18, 3.51) in light, moderate, and heavy smokers with a high seafood/fish intake, respectively, compared with never smokers with a high seafood/fish intake. Similar associations were found for myocardial infarction and nonfatal coronary events, while no difference between low and high seafood/fish consumers was found for risk of fatal coronary events.
Sex-specific analysis (Web Table 1 ) revealed no difference in the association between smoking status and risk of CHD in all men and women. Because of the small number of female smokers and the very small numbers of cases among light, moderate, and heavy female smokers, the attenuated risk of CHD in female smokers with a high seafood/fish intake was still observed, but the confidence intervals were widened.
The highest age-adjusted incidence rate for CHD (0.16 cases per 1,000 person-years) was observed in heavy smokers who consumed less seafood/fish; therefore, we used this group as our reference group in Figure 1 and Web Table 2 , to evaluate risk in the other 9 combination groups of seafood/fish intake and smoking status. The risk of CHD was lower in subjects with a high seafood/fish intake across the different current smoking strata (light, moderate, and heavy) but did not reach the lower risk observed in never or former smokers. Compared with heavy smokers with a low seafood/fish intake, heavy smokers with a high seafood/fish intake had a 23% reduction in the risk of CHD. In addition, compared with that in heavy smokers, the reduced risk of CHD varied in light and moderate smokers according to their seafood/fish intake, with a significant reduction in light smokers with a high seafood/fish intake; the multivariableadjusted hazard ratios for CHD were 0.74 (95% CI: 0.48, (8) 15 (8) 15 (9) 14 (9) 14 (8) Monounsaturated fats, g 22 (10) 18 (10) 18 (10) 17 (11) 16 (10) n-3 fatty acids, g 2.3 (0. (7) 15 (7) 17 (9) 15 (7) 14 (7) Monounsaturated fats, g 24 (9) 20 (9) 22 (11) 20 (9) 19 (9) n-3 fatty acids, g 3. Abbreviation: SD, standard deviation. a Light smoking was defined as <20 cigarettes/day, moderate smoking as 20-29 cigarettes/day, and heavy smoking as ≥30 cigarettes/day. b Low seafood/fish intake was defined as less than the median intake (<86 g/day); high seafood/fish intake was defined as the median intake or more (≥86 g/day).
c Weight (kg)/height (m) 2 .
respectively, in those with high seafood/fish intake. Risk of CHD in subjects who had never smoked or had quit smoking was much lower but did not vary according to seafood/fish intake; the multivariable-adjusted hazard ratios for CHD were 0.32 (95% CI: 0.22, 0.48) and 0.39 (95% CI: 0.26, 0.59), respectively, in those with low seafood/fish intake and 0.32 (95% CI: 0.19, 0.55) and 0.44 (95% CI: 0.29, 0.69), respectively, in those with high seafood/fish intake. Similar associations were observed for myocardial infarction and nonfatal coronary events (Web Table 2 ).
DISCUSSION
In this large cohort study of the Japanese general population, high seafood/fish intake attenuated the excess risk of CHD among current smokers. Light smokers with high seafood/fish intake had a substantially reduced risk, but it did not reach the lower risk of never or former smokers. High seafood/fish intake added little to the risk of CHD among never and former smokers. That observed association was independent of other measured risk factors.
The responses to endothelial injury caused by smoking (15) may be counteracted by effects of n-3 fatty acids from seafood/fish intake (3, 5, 12) . This makes sense given the multiple biological pathways that are affected by n-3 fatty acids. They include the lowering of blood pressure levels and dyslipidemia, especially high levels of triglycerides, improvement of vascular function, inhibition of inflammatory responses and platelet aggregation, and reduction of lowdensity lipoprotein uptake in the aorta (16) (17) (18) (19) . Furthermore, the associations of n-3 fatty acids with reduced cardiac arrhythmias (20) and reduced inflammation within advanced atherosclerotic plaques (21, 22) and maintained heart rate variability (23) would be expected to promote secondary prevention. One of these biological pathways is the alteration of arachidonic acid metabolism, leading to the following: inhibition of leukotriene B 4 syntheses (a chemoattractant), syntheses of the physiologically inactive thromboxane A 3 instead of thromboxane A 2 (a potent vasoconstrictor and pro-aggregator of platelets), and syntheses of prostaglandin I 2 (a vasodilator and platelet anti-aggregator) (24) .
In JPHC Study cohort I, Iso et al. (5) demonstrated an inverse association between fish intake and risk of CHD in 41,578 middle-aged subjects (40-59 years) during 11 years of follow-up. The present analysis extended the follow-up time for cohort I to 15 years, with the addition of subjects from cohort II (n = 72,012 for both cohorts combined), and revealed that high seafood/fish intake may limit the adverse effects of smoking among current smokers, especially light smokers.
Our results among subjects with low seafood/fish intake are consistent with the findings by Rodriguez et al. in the Honolulu Heart Program (12) showing a positive dose-response association between smoking and risk of CHD. However, in the study by Rodriguez et al. (12) , the inverse association between high fish intake and CHD risk was observed only in heavy smokers, whereas in the current study a decreased risk of CHD associated with high seafood/fish intake was observed for all of the current smoking strata and reached a level of significance in light smokers. Our results suggest that the positive dose-response association between smoking and risk of CHD could be interrupted by increasing seafood/fish intake, especially in lighter smokers; this is supported by the lack of excess CHD risk in light-to-moderate smokers with a high seafood/fish intake (compared with never smokers) and by the reduced CHD risk in light, moderate, and heavy smokers with a high seafood/fish intake (compared with heavy smokers with a low seafood/fish intake). On the other hand, Rodriguez et al. did not explain why the inverse association between high fish intake and CHD risk in their study was evident only in subjects who smoked ≥30 cigarettes/day, not in those who smoked <30 cigarettes/day (12). Rodriguez et al. claimed that random error explained the higher CHD risk found in light smokers with a high fish intake compared with light smokers with a low fish intake (12) .
In the current study, the risk of fatal coronary events did not vary according to seafood/fish intake in current smokers or nonsmokers. Previously, Iso et al. (5) found no association between fish intake and risk of fatal coronary events among subjects in JPHC cohort I. These findings contrast with the results reported by many Western investigators (25) but agree with those of other Japanese investigators (3, 26) . One of the reasons for the lack of a significant association with fatal coronary events may be low statistical power (40%) to detect an association. Another reason is potential misdiagnosis of fatal coronary events. In the present study, only 27% of fatal coronary events were confirmed by laboratory findings or autopsy, whereas 98% of nonfatal coronary events were confirmed clinically and by investigative tests. It is possible that almost every subject in the present study population was above a threshold of seafood/fish intake for prevention of fatal coronary events. In our study, the lowest seafood/fish intake was 44 g/day in heavy smokers with a low seafood/fish intake and the highest intake was 151 g/day in moderate smokers with a high seafood/fish intake. One potential reason why a strong inverse association with nonfatal coronary events was seen in this cohort but is not generally seen in Western populations is that seafood/fish intake may affect coronary risk only at very high levels of intake. Here, it seems to contradict the findings obtained among Greeks by Panagiotakos et al. (13) , who reported a J-shaped association between fish intake and CHD risk among smokers, showing that only moderate fish intake (not high fish intake) was associated with reduced risk of CHD. However, the Greek study was a case-control study and was liable to have contained recall bias; furthermore, high-risk subjects may have attempted to eat more fish or may have overestimated their real intake, because self-reported fish intake in that study showed a crossvalidation concordance of 88% for patients and 95% for controls (13) .
The strengths of the current study include its large sample size, the population-based prospective design, the inclusion of both men and women, and the use of validated FFQs. The analyses performed in the present study were based on energyadjusted measures of fish intake. We considered changes in seafood/fish intake and smoking habits over time by updating the data from the 10-year follow-up questionnaire. Furthermore, our study of the Japanese population allowed us to assess any potential association between smoking and risk of CHD at relatively high levels of seafood/fish intake. Table continues 1178 Eshak et al.
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As for limitations, we excluded 5,554 subjects with implausible energy intakes or missing information on seafood/fish intake or smoking status. Although these exclusions were necessary for the current analysis, we could not rule out the possibility of selection bias resulting from these exclusions. The moderate-to-weak correlations for reproducibility of some types of seafood/fish is another limitation. Lastly, we adjusted for a variety of potential confounders; however, we cannot rule out the possibility of unmeasured and residual confounding.
In conclusion, in this prospective study of Japanese populations with different smoking habits (never, former, light, moderate, and heavy smokers), who were unique in having a very high intake of seafood/fish and a very low incidence Abbreviations: CI, confidence interval; HR, hazard ratio. a The P value for interaction between seafood/fish intake and smoking stratum (Wald test) was less than 0.05 for all endpoints except fatal coronary events.
b Light smoking was defined as <20 cigarettes/day, moderate smoking as 20-29 cigarettes/day, and heavy smoking as ≥30 cigarettes/day. c Adjusted for age and sex. d Adjusted for age; sex; alcohol intake; body mass index; histories of hypertension and diabetes; use of medication for hypercholesterolemia; sports during leisure time; public health center; and dietary intake (in quintiles) of fruits, vegetables, saturated fat, monounsaturated fat, n-6 polyunsaturated fat, cholesterol, and total energy.
e Low seafood/fish intake was defined as less than the median intake (<86 g/day); high seafood/fish intake was defined as the median intake or more (≥86 g/day).
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of CHD, we investigated the impact of seafood/fish intake on the associations between smoking and CHD risk in both men and women combined and sex-specifically. To our knowledge, this was the first study of its kind. Our results support a public health message suggesting a reduction of CHD risk among current smokers through an increase in seafood/fish intake. We are not recommending eating seafood/fish as an antidote to smoking, because smoking cessation is one of the best ways to prevent CHD. However, the recommendation of increasing seafood/fish intake is an alternative in the prevention of CHD when the subject is resistant to quitting smoking. Nonsmokers still have the lowest risk of CHD, regardless of their seafood/fish intakes.
